| Application no. and date | 15817641.2 (espacenet) (Federated) (European Patent Register), 20151203 | | Patent/reg. no. and date | DK/EP 3226841, 20241009 | | Publication date | 20171011 | | Priority no. and date | EP 14196594, 20141205 | | EP pub. no. and date |
EP 3226841 20171011 | | Effective date | | | Applicant/owner | Aragon Pharmaceuticals, Inc., 800/850 Ridgeview Drive
Horsham, PA 19044, US | | Applicant ref. no. | | | Inventor | HESTER, Dennis Martin, 10504 Abalone Landing Terrace
San Diego, California 92130, US,
VAUGHN, Jason Michael, c/o Patheon
4125 Premier Drive
High Point, North Carolina 27265, US | | Representative | | | Opponent | | | IPC Class | A61K 31/4184 (2006.01) , A61K 9/14 (2006.01) , A61K 9/20 (2006.01) , A61P 35/00 (2006.01) | | Title | ANTICANCER COMPOSITIONS | | Int. application no. | US2015063661 | | Int. publication no. | WO2016090098 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
